SAM vs VRTX · rev $2.01B vs P/E 30, rev $12.00B
Boston Beer Company Inc (SAM) versus Vertex Pharmaceuticals Inc (VRTX) — a side-by-side from cached financials, not a winner call.
Boston Beer Company Inc (SAM) is a beverages - brewers company listed on NYSE.
Vertex Pharmaceuticals Inc (VRTX) is a biotechnology company listed on US.
Latest reported SAM revenue for 2024-12-28 was $2.01B. Net income was $59.7M. Revenue was up 0.2% from 2023-12-30 to 2024-12-28. SAM currently screens at market cap $1.79B.
Latest reported VRTX revenue for 2025-12-31 was $12.00B. Net income was $3.95B. Revenue was up 8.9% from 2024-12-31 to 2025-12-31. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
SAM currently screens at market cap $1.79B. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
Not investment advice. Open the SAM and VRTX stock pages for the full models.
Not investment advice.